An Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials.
(eBook)
Description
Also in this Series
More Details
Notes
Citations
United States. (2021). An Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials . [U.S. Government Publishing Office].
Chicago / Turabian - Author Date Citation, 17th Edition (style guide)United States. 2021. An Act to Direct the Comptroller General of the United States to Complete a Study On Barriers to Participation in Federally Funded Cancer Clinical Trials By Populations That Have Been Traditionally Underrepresented in Such Trials. [U.S. Government Publishing Office].
Chicago / Turabian - Humanities (Notes and Bibliography) Citation, 17th Edition (style guide)United States. An Act to Direct the Comptroller General of the United States to Complete a Study On Barriers to Participation in Federally Funded Cancer Clinical Trials By Populations That Have Been Traditionally Underrepresented in Such Trials [U.S. Government Publishing Office], 2021.
MLA Citation, 9th Edition (style guide)United States. An Act to Direct the Comptroller General of the United States to Complete a Study On Barriers to Participation in Federally Funded Cancer Clinical Trials By Populations That Have Been Traditionally Underrepresented in Such Trials [U.S. Government Publishing Office], 2021.
Staff View
Grouping Information
Grouped Work ID | bc56512b-c2f2-7383-97e0-0208009b9aac-eng |
---|---|
Full title | act to direct the comptroller general of the united states to complete a study on barriers to participation in federally funded cancer clinical trials by populations that have been traditionally under |
Author | united states |
Grouping Category | book |
Last Update | 2023-05-05 15:45:20PM |
Last Indexed | 2024-04-21 00:46:58AM |
Book Cover Information
Image Source | default |
---|---|
First Loaded | Sep 12, 2022 |
Last Used | Dec 28, 2023 |
Marc Record
First Detected | Mar 30, 2021 12:00:00 AM |
---|---|
Last File Modification Time | May 05, 2023 03:52:34 PM |
MARC Record
LEADER | 02433cam a2200505 i 4500 | ||
---|---|---|---|
001 | on1243899589 | ||
003 | OCoLC | ||
005 | 20210614144401.0 | ||
006 | m o d f | ||
007 | cr ||||||||||| | ||
008 | 210330s2021 dcu ol f000 0 eng c | ||
040 | |a GPO|b eng|e rda|e pn|c GPO|d OCLCO|d OCLCF|d GPO|d MvI | ||
042 | |a pcc | ||
043 | |a n-us--- | ||
074 | |a 0575-A-02 (online) | ||
086 | 0 | |a AE 2.110:116-291 | |
088 | |a Public Law 116-291 | ||
099 | |a AE 2.110:116-291 | ||
110 | 1 | |a United States,|e enacting jurisdiction. | |
240 | 1 | 0 | |a Henrietta Lacks Enhancing Cancer Research Act of 2019 |
245 | 1 | 3 | |a An Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials. |
264 | 1 | |a [Washington, D.C.] :|b [U.S. Government Publishing Office],|c [2021] | |
300 | |a 1 online resource (2 unnumbered pages) | ||
336 | |a text|b txt|2 rdacontent | ||
337 | |a computer|b c|2 rdamedia | ||
338 | |a online resource|b cr|2 rdacarrier | ||
500 | |a "Jan. 5, 2021 (H.R. 1966)." | ||
500 | |a "134 Stat. 4894." | ||
500 | |a "Public Law 116-291." | ||
500 | |a GPO Cataloging Record Distribution Program (CRDP). | ||
588 | |a Description based on online resource; title from PDF title page (govinfo website, viewed March 30, 2021). | ||
650 | 0 | |a Cancer|x Research|z United States. | |
650 | 0 | |a HeLa cells. | |
650 | 0 | |a Minorities|x Health and hygiene|z United States. | |
650 | 7 | |a Cancer|x Research.|2 fast|0 (OCoLC)fst00845497 | |
650 | 7 | |a HeLa cells.|2 fast|0 (OCoLC)fst00952578 | |
650 | 7 | |a Minorities|x Health and hygiene.|2 fast|0 (OCoLC)fst01023167 | |
651 | 7 | |a United States.|2 fast|0 (OCoLC)fst01204155 | |
655 | 7 | |a Statutes and codes.|2 fast|0 (OCoLC)fst01774314 | |
655 | 7 | |a Statutes and codes.|2 lcgft | |
776 | 0 | 8 | |i Print version:|a United States.|s Henrietta Lacks Enhancing Cancer Research Act of 2019.|t Act to Direct the Comptroller General of the United States to Complete a Study on Barriers to Participation in Federally Funded Cancer Clinical Trials by Populations That Have Been Traditionally Underrepresented in Such Trials|w (OCoLC)1256450821 |
856 | 4 | 0 | |3 PDF version|u https://purl.fdlp.gov/GPO/gpo153604 |
856 | 4 | 0 | |3 Text version|u https://purl.fdlp.gov/GPO/gpo153605 |
922 | |a BIBCONEW|b 20210330 | ||
949 | |a AE 2.110:116-291|t x |